🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share my PhD work in the @TobiasMeyerLab, out now in Molecular Cell! “CDT1 inhibits CMG helicase in early S phase to separate origin licensing from DNA synthesis” 1/11 cell.com/molecular-cell…

EXCITING NEWS!! 📌The #BlackinCancer PostDoc Fellowship in collaboration with the Emerald foundation is back for its third cycle! Read all about this incredible funding opportunity & be sure to submit your letter of inquiry by July 15, 2023: bit.ly/bicopps

Postdoc position(s) available! We are broadly interested in the molecular mechanisms linking cellular growth and form. We are interested in the mechanisms cell use to regulate their size, and why they do it. 1/4

Exciting new work from the labs of dana_peer and Lowe Lab on cell plasticity in PDAC initiation! Congrats Cassandra Burdziak and Direna Alonso-Curbelo!

Congrats Alyssa Kaiser and Laura Attardi lab on an awesome story!

Watching high schoolers go from holding a pipette for the first time to presenting a poster with real data they generated was definitely a highlight of the summer!

What an amazing weekend! Grateful to be part of the Lowe lab family, and looking forward to continuing the tradition of excellent science! #LoweLab25

I highly recommend this program! (And am definitely not biased...)

Congratulations Endeavor team at Stanford School of Medicine: Julien Sage, K. Christopher Garcia, Rogelio Hernández-López, Crystal Mackall, MD Julien Sage Rogelio Hernández-López Stanford Cancer Institute Stanford Pediatrics

Thanks to The Mark Foundation for Cancer Research for their outstanding support! Excited to dig deep into #senescence biology to harness its potential for improving #immunooncology outcomes, w/ fantastic team #JulioGarciaAguillar dana_peer Paul Romesser @Michel_Sadelain The SchietiLab.

Excited to see what comes out of the Yang lab! Glad to have you in NYC 🎉

Have you been thinking about how to make megabase-sized deletions? Does MACHETE ring a bell, but maybe the details seem daunting? Fret no more, since our protocol has just been published Nature Protocols! nature.com/articles/s4159… Vall d’Hebron Institute of Oncology (VHIO) Memorial Sloan Kettering Cancer Center

Thrilled to unveil a preprint of my postdoc work unveiling powerful new 🐭 models to study lineage plasticity (adeno>NEPC). Much much more to come! The Charles Sawyers Lab dana_peer HHMI

Congrats Almudena Chaves 🎉 very much well-deserved!

Very grateful to have had the chance to attend the Cold Spring Harbor Laboratory #PancreaticCancerWorkshop last week. Lots of good science, good people, and good views all in one place. Now back to the lab!

Paper out!📢 Anupriya Singhal and #HannahStyers from the lab find acute resistance to targeting KRAS in pancreas cancer is surprisingly driven by a classical epithelial state. Co-targeting classical cells and KRAS augments response - clinically important! aacrjournals.org/cancerdiscover…

Curious to know what people think about the concept of ENT (Epithelial-to-Neuronal Transition) as a parallel to EMT (Epithelial-to-Mesenchymal Transition) in tumorigenesis? See our review with Griffin Hartmann in the lab: tinyurl.com/2x8xtw5j

🚨🚨Now online Nature Cancer, my postdoc work in The Charles Sawyers Lab with dana_peer 🚨🚨 we establish a powerful organoid transplantation model of prostate cancer neuroendocrine transformation. Open access for all! HHMI nature.com/articles/s4301… A 🧵... /1

The Lowe Lab is participating in Cycle for Survival to raise money for rare cancer research at Memorial Sloan Kettering Cancer Center! No amount is too small. Click the link to donate and learn more. Thanks!! secure2.convio.net/mskcc/site/TR?…

After a pandemic-triggered hiatus, the 'Lowe riders' are back to support Cycle for Survival, an event hosted by Equinox where teams cycle to raise funds for rare cancer research at MSKCC. Please consider supporting our team at the link below!👇 tinyurl.com/4xuxdnmm